Close Menu

NEW YORK – Microbiology testing and diagnostics firm PathoQuest today announced the closing of an €8 million ($8.9 million) financing round.

The funding includes a loan from Norgine Ventures and financing from previous investors Kurma Partners, Idinvest Partners, and Charles River Labs, as well as new investor Investiere.

The money includes €427,000 in non-dilutive funding from the French public investment program Investissement d'Avenir concours d'innovation i-Nov.

Other details, including PathoQuest's intended use of the funds, were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.